Cummings, Jeffrey
Article History
First Online: 25 November 2021
Competing interests
: J.C. has provided consultation to Acadia, Alkahest, Behren Therapeutics, Biogen, Cassava, Cortexyme, EIP Pharma, Eisai, GemVax, Genentech, Green Valley, Grifols, Janssen, Karuna, LSP, Merck, Novo Nordisk, Otsuka, ReMYND, Resverlogix, Roche, Signant Health, Vaxxinity, and Unlearn AI pharmaceutical and assessment companies. J.C. owns the copyright of the Neuropsychiatric Inventory. J.C. has the following research support: NIGMS P20GM109025; NINDS U01NS093334; NIA R01AG053798; NIA P20AG068053; and NIA R35AG71476.